Buprenorphine is a weak partial agonist that inhibits opioid receptor desensitization

Michael S. Virk, Seksiri Arttamangkul, William T. Birdsong, John Williams

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Buprenorphine is a weak partial agonist at μ-opioid receptors that is used for treatment of pain and addiction. Intracellular and whole-cell recordings were made from locus ceruleus neurons in rat brain slices to characterize the actions of buprenorphine. Acute application of buprenorphine caused a hyperpolarization that was prevented by previous treatment of slices with the irreversible opioid antagonist β-chlornaltrexamine (β-CNA) but was not reversed by a saturating concentration of naloxone. As expected for a partial agonist, subsaturating concentrations of buprenorphine decreased the [Met]5enkephalin (ME)-induced hyperpolarization or outward current. When the ME-induced current was decreased below a critical value, desensitization and internalization of β-opioid receptors was eliminated. The inhibition of desensitization by buprenorphine was not the result of previous desensitization, slow dissociation from the receptor, or elimination of receptor reserve. Treatment of slices with subsaturating concentrations of etorphine, methadone, oxymorphone, or β-CNA also reduced the current induced by ME but did not block ME-induced desensitization. Treatment of animals with buprenorphine for 1 week resulted in the inhibition of the current induced by ME and a block of desensitization that was not different from the acute application of buprenorphine to brain slices. These observations show the unique characteristics of buprenorphine and further demonstrate the range of agonist-selective actions that are possible through G-protein-coupled receptors.

Original languageEnglish (US)
Pages (from-to)7341-7348
Number of pages8
JournalJournal of Neuroscience
Volume29
Issue number22
DOIs
StatePublished - Jun 3 2009

Fingerprint

Buprenorphine
Opioid Receptors
Oxymorphone
Etorphine
Locus Coeruleus
Narcotic Antagonists
Methadone
Brain
Patch-Clamp Techniques
Therapeutics
Naloxone
G-Protein-Coupled Receptors
Psychologic Desensitization
Neurons
Pain

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Buprenorphine is a weak partial agonist that inhibits opioid receptor desensitization. / Virk, Michael S.; Arttamangkul, Seksiri; Birdsong, William T.; Williams, John.

In: Journal of Neuroscience, Vol. 29, No. 22, 03.06.2009, p. 7341-7348.

Research output: Contribution to journalArticle

@article{0ba9be7afba34eea86022672df59ecc2,
title = "Buprenorphine is a weak partial agonist that inhibits opioid receptor desensitization",
abstract = "Buprenorphine is a weak partial agonist at μ-opioid receptors that is used for treatment of pain and addiction. Intracellular and whole-cell recordings were made from locus ceruleus neurons in rat brain slices to characterize the actions of buprenorphine. Acute application of buprenorphine caused a hyperpolarization that was prevented by previous treatment of slices with the irreversible opioid antagonist β-chlornaltrexamine (β-CNA) but was not reversed by a saturating concentration of naloxone. As expected for a partial agonist, subsaturating concentrations of buprenorphine decreased the [Met]5enkephalin (ME)-induced hyperpolarization or outward current. When the ME-induced current was decreased below a critical value, desensitization and internalization of β-opioid receptors was eliminated. The inhibition of desensitization by buprenorphine was not the result of previous desensitization, slow dissociation from the receptor, or elimination of receptor reserve. Treatment of slices with subsaturating concentrations of etorphine, methadone, oxymorphone, or β-CNA also reduced the current induced by ME but did not block ME-induced desensitization. Treatment of animals with buprenorphine for 1 week resulted in the inhibition of the current induced by ME and a block of desensitization that was not different from the acute application of buprenorphine to brain slices. These observations show the unique characteristics of buprenorphine and further demonstrate the range of agonist-selective actions that are possible through G-protein-coupled receptors.",
author = "Virk, {Michael S.} and Seksiri Arttamangkul and Birdsong, {William T.} and John Williams",
year = "2009",
month = "6",
day = "3",
doi = "10.1523/JNEUROSCI.3723-08.2009",
language = "English (US)",
volume = "29",
pages = "7341--7348",
journal = "Journal of Neuroscience",
issn = "0270-6474",
publisher = "Society for Neuroscience",
number = "22",

}

TY - JOUR

T1 - Buprenorphine is a weak partial agonist that inhibits opioid receptor desensitization

AU - Virk, Michael S.

AU - Arttamangkul, Seksiri

AU - Birdsong, William T.

AU - Williams, John

PY - 2009/6/3

Y1 - 2009/6/3

N2 - Buprenorphine is a weak partial agonist at μ-opioid receptors that is used for treatment of pain and addiction. Intracellular and whole-cell recordings were made from locus ceruleus neurons in rat brain slices to characterize the actions of buprenorphine. Acute application of buprenorphine caused a hyperpolarization that was prevented by previous treatment of slices with the irreversible opioid antagonist β-chlornaltrexamine (β-CNA) but was not reversed by a saturating concentration of naloxone. As expected for a partial agonist, subsaturating concentrations of buprenorphine decreased the [Met]5enkephalin (ME)-induced hyperpolarization or outward current. When the ME-induced current was decreased below a critical value, desensitization and internalization of β-opioid receptors was eliminated. The inhibition of desensitization by buprenorphine was not the result of previous desensitization, slow dissociation from the receptor, or elimination of receptor reserve. Treatment of slices with subsaturating concentrations of etorphine, methadone, oxymorphone, or β-CNA also reduced the current induced by ME but did not block ME-induced desensitization. Treatment of animals with buprenorphine for 1 week resulted in the inhibition of the current induced by ME and a block of desensitization that was not different from the acute application of buprenorphine to brain slices. These observations show the unique characteristics of buprenorphine and further demonstrate the range of agonist-selective actions that are possible through G-protein-coupled receptors.

AB - Buprenorphine is a weak partial agonist at μ-opioid receptors that is used for treatment of pain and addiction. Intracellular and whole-cell recordings were made from locus ceruleus neurons in rat brain slices to characterize the actions of buprenorphine. Acute application of buprenorphine caused a hyperpolarization that was prevented by previous treatment of slices with the irreversible opioid antagonist β-chlornaltrexamine (β-CNA) but was not reversed by a saturating concentration of naloxone. As expected for a partial agonist, subsaturating concentrations of buprenorphine decreased the [Met]5enkephalin (ME)-induced hyperpolarization or outward current. When the ME-induced current was decreased below a critical value, desensitization and internalization of β-opioid receptors was eliminated. The inhibition of desensitization by buprenorphine was not the result of previous desensitization, slow dissociation from the receptor, or elimination of receptor reserve. Treatment of slices with subsaturating concentrations of etorphine, methadone, oxymorphone, or β-CNA also reduced the current induced by ME but did not block ME-induced desensitization. Treatment of animals with buprenorphine for 1 week resulted in the inhibition of the current induced by ME and a block of desensitization that was not different from the acute application of buprenorphine to brain slices. These observations show the unique characteristics of buprenorphine and further demonstrate the range of agonist-selective actions that are possible through G-protein-coupled receptors.

UR - http://www.scopus.com/inward/record.url?scp=66749153181&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=66749153181&partnerID=8YFLogxK

U2 - 10.1523/JNEUROSCI.3723-08.2009

DO - 10.1523/JNEUROSCI.3723-08.2009

M3 - Article

C2 - 19494155

AN - SCOPUS:66749153181

VL - 29

SP - 7341

EP - 7348

JO - Journal of Neuroscience

JF - Journal of Neuroscience

SN - 0270-6474

IS - 22

ER -